The invention pertains to nucleic acids encoding a cbl-SL protein,
including fragments and biologically functional variants thereof. The
invention also pertains to therapeutics and diagnostics involving the
foregoing proteins and genes and agents that bind the foregoing proteins
and genes.
A invenção pertence aos ácidos nucleic que codificam uma proteína cbl-Cbl-SL, including fragmentos e variants biològica funcionais disso. A invenção pertence também ao therapeutics e o diagnóstico que envolvem as proteínas e os genes e os agentes antecedentes que ligam as proteínas e os genes antecedentes.
